[go: up one dir, main page]

TR200103856T2 - Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar. - Google Patents

Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar.

Info

Publication number
TR200103856T2
TR200103856T2 TR2001/03856T TR200103856T TR200103856T2 TR 200103856 T2 TR200103856 T2 TR 200103856T2 TR 2001/03856 T TR2001/03856 T TR 2001/03856T TR 200103856 T TR200103856 T TR 200103856T TR 200103856 T2 TR200103856 T2 TR 200103856T2
Authority
TR
Turkey
Prior art keywords
cell
naftiridine
derivatives
pharmaceutical compositions
preparation processes
Prior art date
Application number
TR2001/03856T
Other languages
English (en)
Inventor
Peyman Anuschirwan
Scheunemann Karlheinz
R. Gadek Thomas
Gourvest Jean-Francois
Ruxer Jean-Marie
Original Assignee
Aventis Pharma Deutschland Gmbh
Genentech, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh, Genentech, Inc. filed Critical Aventis Pharma Deutschland Gmbh
Publication of TR200103856T2 publication Critical patent/TR200103856T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Mevcut bulus, B, G, Z, X, Y, r, s ve t' nin istemlerde belirtilen anlamlara geldigi formül (I)' e ait bilesiklerle, bunlarin fizyolojik açidan tolere edilebilir tuzlari ve ön ilaçlariyla ilgilidir. Formül (I)' e ait bilesikler, farmakolojik açidan aktif degerli bilesiklerdir. Bunlar, vitronektin alici antagonistleri ve hücre yapismasinin önleyicilerdir ve bunlar, hücre-hücre veya hücre-matris etkilesim süreçlerinde vitronektin alicilari ile bunlarin ligantlari arasindaki etkilesime dayanan veya bu etkilesimlerin etkilenmesiyle önlenebilen, iyilestirilebilen veya tedavi edilebilen hastaliklarin terapisi ve profilaksisi için uygundur.
TR2001/03856T 1999-07-02 2000-06-26 Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar. TR200103856T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99112636A EP1065207A1 (en) 1999-07-02 1999-07-02 Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them

Publications (1)

Publication Number Publication Date
TR200103856T2 true TR200103856T2 (tr) 2002-06-21

Family

ID=8238482

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03856T TR200103856T2 (tr) 1999-07-02 2000-06-26 Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar.

Country Status (33)

Country Link
US (2) US6743800B1 (tr)
EP (2) EP1065207A1 (tr)
JP (1) JP2003503496A (tr)
KR (1) KR20020015996A (tr)
CN (1) CN1160356C (tr)
AR (1) AR024622A1 (tr)
AT (1) ATE305471T1 (tr)
AU (1) AU775386B2 (tr)
BG (1) BG106257A (tr)
BR (1) BR0012129A (tr)
CA (1) CA2376668C (tr)
CZ (1) CZ20014605A3 (tr)
DE (2) DE60022890D1 (tr)
DK (1) DK1210348T3 (tr)
EA (1) EA004369B1 (tr)
EE (1) EE200100711A (tr)
ES (1) ES2250157T3 (tr)
HK (1) HK1050003B (tr)
HR (1) HRP20010946A2 (tr)
HU (1) HUP0203539A3 (tr)
IL (1) IL147248A0 (tr)
MX (1) MXPA01013435A (tr)
MY (1) MY133246A (tr)
NO (1) NO20016404L (tr)
NZ (1) NZ516058A (tr)
PL (1) PL352280A1 (tr)
SK (1) SK19132001A3 (tr)
TR (1) TR200103856T2 (tr)
TW (1) TW593319B (tr)
UA (1) UA73133C2 (tr)
WO (1) WO2001002398A1 (tr)
YU (1) YU92201A (tr)
ZA (1) ZA200200016B (tr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1065207A1 (en) * 1999-07-02 2001-01-03 Aventis Pharma Deutschland GmbH Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
DE10042655A1 (de) 2000-08-31 2002-03-14 Aventis Pharma Gmbh Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion
FR2847254B1 (fr) 2002-11-19 2005-01-28 Aventis Pharma Sa Nouveaux derives antagonistes du recepteur de la vitronectine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les refermant
WO2005016910A1 (ja) 2003-08-18 2005-02-24 Sankio Chemical Co., Ltd. ピリジルテトラヒドロピリジン類およびピリジルピペリジン類とそれらの製造方法
FR2870541B1 (fr) 2004-05-18 2006-07-14 Proskelia Sas Derives de pyrimidines antigonistes du recepteur de la vitronectine
US20110237605A1 (en) * 2010-03-26 2011-09-29 Eric Phillips Molecular Crystal of (4-(1,8-Naphthyridin-2-YL)Piperidin-1-YL)Pyrimidine Derivative
CN107312039B (zh) 2012-08-30 2019-06-25 江苏豪森药业集团有限公司 一种替诺福韦前药的制备方法
ES2899860T3 (es) 2013-09-24 2022-03-15 Fujifilm Corp Nuevo compuesto que contiene nitrógeno o sal del mismo, o complejo de metal de los mismos
US12509455B2 (en) 2018-11-07 2025-12-30 Dana-Farber Cancer Institute, Inc. Imidazopyridine derivatives and aza-imidazopyridine derivatives as Janus kinase 2 inhibitors and uses thereof
EP3876939A4 (en) 2018-11-07 2022-08-10 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
WO2020097396A1 (en) 2018-11-07 2020-05-14 Dana-Farber Cancer Institute, Inc. Benzimidazole derivatives and aza-benzimidazole derivatives as janus kinase 2 inhibitors and uses thereof
CA3181537A1 (en) 2020-05-06 2021-11-11 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
EP4267574B1 (en) 2020-12-23 2025-04-23 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
WO2023086319A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
US12162881B2 (en) 2021-11-09 2024-12-10 Ajax Therapeutics, Inc. Forms and compositions of inhibitors of JAK2

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69528829T2 (de) * 1994-05-27 2003-08-07 Merck & Co., Inc. Präparate zur hemmung der durch osteoklasten vermittelten knochenresorption
WO1998008940A1 (en) 1996-08-26 1998-03-05 Novo Nordisk A/S A novel endoglucanase
CA2263999A1 (en) * 1996-08-29 1998-03-05 Merck & Co., Inc. Integrin antagonists
AU717283B2 (en) * 1996-10-30 2000-03-23 Merck & Co., Inc. Integrin antagonists
DE19653646A1 (de) * 1996-12-20 1998-06-25 Hoechst Ag Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
EP1007026A4 (en) * 1997-01-17 2002-08-07 Merck & Co Inc Integrin antagonists
EP0933367A1 (en) * 1997-12-19 1999-08-04 Hoechst Marion Roussel Deutschland GmbH Novel acylguanidine derivates as inhibitors of bone resorption and as vitronectin receptor antagonists
UA63990C2 (uk) * 1998-01-23 2004-02-16 Авентіс Фарма Дойчланд Гмбх Сульфонамідні похідні, спосіб їх одержання та фармацевтична композиція на їх основі
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
US6365589B1 (en) * 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
EP1065207A1 (en) * 1999-07-02 2001-01-03 Aventis Pharma Deutschland GmbH Naphthyridine derivatives, processes for their preparation, their use, and pharmaceutical compositions comprising them
DE10042655A1 (de) * 2000-08-31 2002-03-14 Aventis Pharma Gmbh Verfahren zur Herstellung von Inhibitoren der Zell-Adhäsion
WO2003059289A2 (en) * 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted benzoimidazole analogues
JP2008047614A (ja) 2006-08-11 2008-02-28 Showa Shell Sekiyu Kk 吸着材を利用した改良型太陽電池モジュール

Also Published As

Publication number Publication date
EE200100711A (et) 2003-04-15
ATE305471T1 (de) 2005-10-15
EP1065207A1 (en) 2001-01-03
MXPA01013435A (es) 2002-07-22
US20040198718A1 (en) 2004-10-07
DE60022890T2 (de) 2006-06-29
JP2003503496A (ja) 2003-01-28
UA73133C2 (en) 2005-06-15
CN1372559A (zh) 2002-10-02
CA2376668A1 (en) 2001-01-11
CZ20014605A3 (cs) 2002-06-12
HK1050003A1 (en) 2003-06-06
TW593319B (en) 2004-06-21
YU92201A (sh) 2004-07-15
BR0012129A (pt) 2002-05-07
DE60022890D1 (de) 2006-02-09
US6743800B1 (en) 2004-06-01
ZA200200016B (en) 2003-01-02
KR20020015996A (ko) 2002-03-02
EP1210348B1 (en) 2005-09-28
NZ516058A (en) 2003-01-31
SK19132001A3 (sk) 2002-07-02
IL147248A0 (en) 2002-08-14
HUP0203539A2 (hu) 2003-02-28
HRP20010946A2 (en) 2003-02-28
MY133246A (en) 2007-10-31
EP1210348A1 (en) 2002-06-05
WO2001002398A1 (en) 2001-01-11
PL352280A1 (en) 2003-08-11
EP1210348B9 (en) 2006-04-26
NO20016404D0 (no) 2001-12-28
NO20016404L (no) 2002-03-01
BG106257A (bg) 2002-10-31
HK1050003B (zh) 2005-04-29
DK1210348T3 (da) 2006-01-16
DE60022890T4 (de) 2007-03-29
CA2376668C (en) 2007-01-02
EA200200122A1 (ru) 2002-06-27
AR024622A1 (es) 2002-10-16
EA004369B1 (ru) 2004-04-29
AU5978700A (en) 2001-01-22
ES2250157T3 (es) 2006-04-16
AU775386B2 (en) 2004-07-29
CN1160356C (zh) 2004-08-04
HUP0203539A3 (en) 2005-01-28

Similar Documents

Publication Publication Date Title
TR200103856T2 (tr) Naftiridin türevleri, bunların preparasyon işlemleri, kullanımları ve farmasötik kompozisyonlar.
BR0313942A (pt) Derivados de benzimidazol úteis como agentes antiproliferativos
AR028833A1 (es) Compuestos inhibidores de metaloproteasas, composiciones farmaceuticas, uso para la manufactura de medicamentos, metodo de tratamiento y procedimiento para su preparacion
TR199900920T2 (tr) Nafthiridin türevleri.
BR9916980A (pt) Derivados bicìclicos substituìdos úteis como agentes anticancerìgenos
TR200000520A2 (tr) 4-Fenil-piridin türevleri.
EA200400466A1 (ru) Производные пиперазина с антагонистической активностью к рецептору ccr1
DE60045508D1 (de) Dalda-analoge und ihre verwendung
MY134223A (en) Tropane derivatives as ccr5 modulators
TR199701647A2 (tr) Ikame edilmis purin türevleri,bunlarin imalat usulü
DE59915127D1 (de) Imidazolidinderivate, ihre herstellung, ihre verwendung und sie enthaltende pharmazeutische präparate
TR200002160T2 (tr) Yeni sülfonamid türevleri
ATE233754T1 (de) Diphenyl-piperidin derivate
TR200103858T2 (tr) Hücre yapışmasının önleyicileri olarak ikame edilmiş purin türevleri
ATE368643T1 (de) Faktor xa benzamidin inhibitoren
IT1255802B (it) Derivati imidazolici ad attivita' a ii antagonista
ATE384708T1 (de) Piperazinderivate als aktivitätsmodulatoren der chemokinrezeptoren
FR2767527B1 (fr) Derives de piperazines indoliques, utiles comme medicaments et procede de preparation
DE69720966D1 (de) Benzo[c]chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
TR199901380A2 (tr) Di-ya da triazo-spiro[4,5] dekan türevleri
YU70803A (sh) Derivati imidazolidina, njihovo dobijanje i njihova upotreba kao antiinflamatornih agensa
DK1414444T3 (da) Hidtil ukendte imidasolidinderivater, deres fremstilling og deres anvendelse som VLA-4-antagonister
TR200103278T2 (tr) Spiroimidazolidin türevleri, hazırlanışları, kullanışları ve bunları içeren farmasötik preparatlar.
PL343848A1 (en) Novel benzimidazoles and benzoxazoles
BR0015112A (pt) Composto, método para uso do mesmo, e, produto farmacêutico